Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
about
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future DirectionsNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionCirculating Tumor Cell and Cell-free Circulating Tumor DNA in Lung CancerLiquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoringLiquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB)Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Liquid Biopsy in Non-Small Cell Lung Cancer.The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.Blood-based tumor biomarkers in lung cancer for detection and treatment.Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review.
P2860
Q26781333-0B3C9D64-F832-4E83-89C3-0F538BA125C1Q26801357-4C3DB21F-1762-469F-BE51-C9DFE626952DQ28066285-4CB3EC05-1D3D-4EE2-9C4F-85870F680D74Q28067582-2A986E4B-14F4-41F3-BF46-164DC0CA4C97Q28076191-31F2AEB8-EB44-4453-8B84-47961B0DADBEQ36430821-EC3BC38E-08B0-4099-9003-3E85F59B7DE4Q37468081-A8874BA2-18DD-4123-9910-5376C47EAB6DQ38639962-EAA06CD3-9AF7-4CFC-ABFE-5657699B01F0Q38844281-EC14380A-075B-4BA4-91CF-3BA326D01EE6Q39076207-2D1DB2B3-41A3-4F1A-A616-69B7BB5F9BBCQ39097813-D10BC86D-2DF5-4498-AD68-52F5B4FD518DQ41835612-0F8E884D-3580-46CC-8128-9EA2580984C1Q42097486-FD1C3C98-D115-45E6-BAF3-C610FC742F85Q47110464-F200F0F1-BD73-4209-AB89-BCD9D44AE817Q47126156-4D2FDDB0-12B4-40FA-8FC9-C09165707CDFQ47354317-56881C34-DD46-4757-84A1-43CC1BF2FFDAQ54120286-C3DFC3CA-641D-41E5-88B7-F21418F61C6D
P2860
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a highly sensit ...... all-cell lung cancer patients.
@en
Development of a highly sensit ...... all-cell lung cancer patients.
@nl
type
label
Development of a highly sensit ...... all-cell lung cancer patients.
@en
Development of a highly sensit ...... all-cell lung cancer patients.
@nl
prefLabel
Development of a highly sensit ...... all-cell lung cancer patients.
@en
Development of a highly sensit ...... all-cell lung cancer patients.
@nl
P2093
P2860
P1433
P1476
Development of a highly sensit ...... all-cell lung cancer patients.
@en
P2093
Diana Cortes-Incio
Frank Breitenbuecher
Jens Köhler
Kurt Werner Schmid
Lutz Freitag
Martin Schuler
Sandra Hoffarth
Stefan Kasper
Thomas C Gauler
P2860
P304
P356
10.1371/JOURNAL.PONE.0085350
P407
P577
2014-01-21T00:00:00Z